AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DOXYLAMINE SUCCINATE
10 registrations across 3 African markets— 6 active
Markets with DOXYLAMINE SUCCINATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| DONORMYL 15MG COMPRIME PELLICULE BOITE DE 10 | 🇨🇮Côte d'Ivoire | UPSA SAS | active | Apr 2029 |
| NOMOWAKE | 🇿🇦South Africa | LeBasi Pharmaceuticals (Pty) Ltd | active | Nov 2027 |
| DONORMYL 15MG COMPRIME EFFERVESCENT SECABLE BOITE DE 10 | 🇨🇮Côte d'Ivoire | UPSA SAS | expired | Jul 2026 |
| RESTWEL | 🇿🇦South Africa | Adcock Ingram Limited | suspended | May 2025 |
| SOMNIL DROPS | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| REPOSE | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Nov 2022 |
| SOMNIL | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| DOXYNITE DROPS | 🇿🇦South Africa | ANMARATE (PTY) LTD | active | Jan 1900 |
| LIDENE comprimé / 15 mg | 🇸🇳Senegal | COOPER FRANCE | active | — |
| DONORMYL comprimé pelliculé / 15 mg | 🇸🇳Senegal | UPSA | active | — |
DOXYLAMINE SUCCINATE in Africa — Regulatory Overview
DOXYLAMINE SUCCINATE is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Côte d'Ivoire, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 10 registrations, 6 (60%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.